Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a Locations section showing Guangdong as a study site and updated the footer to Revision: v3.3.3; the prior Guangdong Locations and HHS Vulnerability Disclosure were removed.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedPublications section updated to clarify that entries are automatically filled from PubMed and may not be about the study, and the revision tag was updated to v3.3.2; the deletion note reiterates PubMed as the source with revision tag v3.2.0.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved the government funding lapse notice from the page, including references to NIH Clinical Center operating status and opm.gov updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedThe new screenshot appears to show only UI and layout updates (header, spacing, font) without changes to core trial details such as enrollment, locations, eligibility, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference5%

- Check96 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.